# OnCo record pancreatic-colloid-carcinoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/pancreatic-colloid-carcinoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "pancreatic-colloid-carcinoma" ;
  schema:name "Colloid (mucinous non-cystic) carcinoma of the pancreas"@en ;
  schema:alternateName "Colloid (mucinous non-cystic) carcinoma of the pancreas (mucin pools; usually the invasive part of an intestinal-type IPMN; better outlook)"@en, "Colloid carcinoma of the pancreas"@en, "Mucinous non-cystic carcinoma of the pancreas"@en, "Mucinous noncystic carcinoma"@en, "Colloid carcinoma"@en ;
  schema:description "Colloid carcinoma is a rare form of pancreatic cancer in which the cancer cells float in large pools of mucus rather than forming glands in dense scar. It usually grows out of an intestinal-type IPMN in the main pancreatic duct, presents as a larger but lower-stage tumour, and has a clearly better outlook after surgery than ordinary pancreatic cancer."@en ;
  schema:url <https://onco.cc/cancers/pancreatic-colloid-carcinoma/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mucinous_carcinoma> ;
  schema:citation <https://doi.org/10.1097/00000478-200101000-00003>, <https://doi.org/10.1136/gut.2010.232272>, <https://doi.org/10.1097/sla.0b013e318214bcb4>, <https://doi.org/10.1111/his.13975> ;
  onco:tag "gi", "pancreatic", "subtype-page" ;
  onco:related <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/ipmn-associated-carcinoma/>, <https://onco.cc/cancers/ipmn-cystic-precursors/>, <https://onco.cc/cancers/mcn-associated-carcinoma/>, <https://onco.cc/cancers/colorectal-mucinous-adenocarcinoma/>, <https://onco.cc/cancers/gallbladder-mucinous-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/pancreatic-surveillance/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:pathways <https://onco.cc/pathways/ras-mapk/>, <https://onco.cc/pathways/pancreatic-cancer-signalling/> ;
  onco:terms <https://onco.cc/terms/tumour-grade/>, <https://onco.cc/terms/whipple/>, <https://onco.cc/terms/pancreatic-cyst-high-risk-stigmata/> ;
  onco:standardOfCare <https://onco.cc/terms/whipple/>, <https://onco.cc/terms/distal-pancreatectomy/>, <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/technologies/pancreatic-surveillance/>, <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> .